 Connection
Laurie Goodrich to Interleukin 1 Receptor Antagonist Protein
This is a "connection" page, showing publications Laurie Goodrich has written about Interleukin 1 Receptor Antagonist Protein.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.517 |
|
|
|
-
Goodrich LR, McIlwraith CW, Grieger J, Kraus VB, Stabler T, Werpy N, Phillips J, Samulski RJ, Frisbie D. IL-1ra gene therapy in equine osteoarthritis improves physiological, anatomical, and biological outcomes of joint degeneration. J Am Vet Med Assoc. 2024 06 01; 262(S1):S109-S120.
Score: 0.762
-
Thampi P, Seabaugh KA, Pezzanite LM, Chu CR, Phillips JN, Grieger JC, McIlwraith CW, Samulski RJ, Goodrich LR. A pilot study to determine the optimal dose of scAAVIL-1ra in a large animal model of post-traumatic osteoarthritis. Gene Ther. 2023 12; 30(12):792-800.
Score: 0.730
-
Siegal-Willott JL, Anikis P, Neiffer DL, Barthel T, Goodrich LR. USE OF INTRACARPAL INTERLEUKIN RECEPTOR ANTAGONIST PROTEIN (IRAP) AND HYALURONIC ACID IN A MULTIMODAL THERAPEUTIC REGIME FOR OSTEOARTHRITIS IN AN ASIAN ELEPHANT (ELEPHAS MAXIMUS). J Zoo Wildl Med. 2021 Apr; 52(1):401-405.
Score: 0.616
-
Goodrich LR, Grieger JC, Phillips JN, Khan N, Gray SJ, McIlwraith CW, Samulski RJ. scAAVIL-1ra dosing trial in a large animal model and validation of long-term expression with repeat administration for osteoarthritis therapy. Gene Ther. 2015 Jul; 22(7):536-45.
Score: 0.408
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|